Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.46
-1.52 (-8.01%)
At close: Jun 25, 2025, 4:00 PM
17.69
+0.23 (1.31%)
After-hours: Jun 25, 2025, 7:58 PM EDT
Sarepta Therapeutics Stock Forecast
Stock Price Forecast
The 25 analysts that cover Sarepta Therapeutics stock have a consensus rating of "Buy" and an average price target of $64, which forecasts a 266.55% increase in the stock price over the next year. The lowest target is $10 and the highest is $170.
Price Target: $64 (+266.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sarepta Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 5 | 6 | 4 |
Buy | 13 | 12 | 11 | 12 | 12 | 10 |
Hold | 1 | 1 | 3 | 4 | 5 | 10 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 1 | 0 | 1 |
Total | 22 | 21 | 21 | 22 | 23 | 25 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Sell Downgrades $40 → $10 | Hold → Strong Sell | Downgrades | $40 → $10 | -42.73% | Jun 25, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $123 → $45 | Buy | Maintains | $123 → $45 | +157.73% | Jun 20, 2025 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 20, 2025 |
Mizuho | Mizuho | Buy Maintains $85 → $40 | Buy | Maintains | $85 → $40 | +129.10% | Jun 18, 2025 |
Deutsche Bank | Deutsche Bank | Hold Maintains $50 → $25 | Hold | Maintains | $50 → $25 | +43.18% | Jun 17, 2025 |
Financial Forecast
Revenue This Year
2.41B
from 1.90B
Increased by 26.87%
Revenue Next Year
2.49B
from 2.41B
Increased by 3.15%
EPS This Year
-2.57
from 2.34
EPS Next Year
4.70
from -2.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.0B | 3.9B | 4.0B | ||
Avg | 2.4B | 2.5B | 2.6B | ||
Low | 2.0B | 1.1B | 1.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 55.8% | 63.2% | 59.7% | ||
Avg | 26.9% | 3.1% | 4.6% | ||
Low | 2.6% | -52.7% | -47.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.98 | 14.18 | 15.27 | ||
Avg | -2.57 | 4.70 | 5.88 | ||
Low | -5.76 | -2.12 | -0.46 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -58.2% | - | 225.1% | ||
Avg | - | - | 25.2% | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.